Background:
Experimental studies
indicate that
endogenous
plasminogen
activator
inhibitor-1 (PAI-1,
encoded by the gene
SERPINE1) modulates
the immune response
to
lipopolysaccharide
(LPS). On the other
hand, LPS induces
PAI-1 secretion.
Activation of
individual cells by
LPS is facilitated
by CD14. The single
nucleotide
polymorphisms -675
4G/5G in SERPINE1
and C-159T in CD14
are major
determinants of
PAI-1 and CD14
expression,
respectively.
Objective: To
evaluate the
frequency of the
-675 4G/5G SERPINE1
and C-159T CD14
polymorphisms in
house dust mite (HDM)
allergic asthma
patients.
Methods: The
polymorphisms were
evaluated in
unrelated
inhabitants of
northeastern Poland,
including 372 HDM-allergic
asthmatic patients
and 160 healthy
nonatopic control
subjects using
polymerase chain
reaction.
Results: Both
the C allele of CD14
and the 4G allele of
SERPINE1 were more
frequently
encountered in HDM-allergic
asthmatic patients
than in healthy
control individuals.
When the 5G/5G-TT/CT
genotype was
considered as a
nonrisk genotype,
all other genotypes
were associated with
asthma. The odds
ratios ranged from
3.96 (95% confidence
interval, 1.56-10.1)
for the 5G/5G-CC
genotype to 10.7
(95% confidence
interval, 5.1-24.9)
for the 4G/4G-CC
genotype. Bronchial
reactivity to
histamine and total
serum immunoglobulin
(Ig) E levels were
predominantly
associated with the
4G/5G SERPINE1
variants, while
bronchial reactivity
to Dermatophagoides
pteronyssinus and
serum
concentrations of
specifi c IgE
against D
pteronyssinus were
predominantly
associated with the
C/T CD14 variants.
Patients with
4G/4G-CC genotype
had the lowest
forced expiratory
volume in 1 second
and the highest
bronchial
reactivity.
Conclusion:
The SERPINE1 and
CD14 polymorphisms
studied here are
associated with
different aspects of
bronchial reactivity
and IgE response.
Our results indicate
that PAI-1 and CD14
may interact to
affect
susceptibility to
allergic asthma.
Key words:
Asthma. Genetics.
Innate immunity.
Plasminogen
activator inhibitor.
|